Muñoz EVF, Zapata GA, Piña LF

Language: Spanish
References: 14
Page: 33-36
PDF size: 631.57 Kb.

ABSTRACT

Onychomycosis is a nail infection usually caused by fungi. Onychomycosis due to non-dermatophyte fungi, such as Fusarium, is an emerging disease, the most frequent pathogenic species being F. oxysporum and F. solani. Fusarium is a group of saprophytic fungi in soil and plants, causing diseases in plant and opportunistic infections in humans. Distal and lateral subungual onychomycosis, superficial white, total dystrophic, and paronychia are the most common clinical presentations. We report a 63-yearold woman with a history of type 2 diabetes mellitus and distal subungual onychomycosis in the lower limb caused by Fusarium chlamydosporum, a species rarely reported in this condition.

REFERENCES

1. Herrán P, López H, Fierro L, Ponce R, Hernández M y Bonifaz A, Paroniquia micótica por Fusarium solani: reporte de caso y revisión de la literatura, Dermatología cmq 2012; 10(2):139-42.

2. Ramírez HL, Gómez-Sáenz A, Vega S et al., Onicomicosis por mohos no dermatofitos. Una revisión, Dermatología cmq 2017; 15(3):184-95.

3. Monod M y Méhul B, Recent findings in onychomycosis and their application for appropriate treatment, J Fungi 2019; 5(1):1-22.

4. Dalyan B, Hatmi A, Seyedmousavi S, Rijs A, Verweij P, Ener B et al., Emergence of fusarioses in a university hospital in Turkey during a 20- year period, Eur J Clin Microbiol Infect Dis 2015; 34(8):1683-91.

5. Batista B, De Chaves M, Reginatto P, Jaconi O y Meneghello A, Human fusariosis: an emerging infection that is difficult to treat, Rev Soc Bras Med Tro 2020; 50:1-7.

6. Bonifaz TJ, Micología médica básica, México, McGraw-Hill Interamericana, 2012, pp. 447-8.

7. Muhammed M, Anagnostou T, Desalermos A, Kourkoumpetis TK, Carneiro HA, Glavis-Bloom J, Coleman JJ y Mylonakis E, Fusarium infection: report of 26 cases and review of 97 cases from the literatura, Medicine (Baltimore) 2013; 92(6):305-16

8. Tosti A, Piraccini BM y Lorenzi S, Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases, J Am Acad Dermatol 2000; 42(2):217-24.

9. Monod M y Méhul B. “Recent findings in onychomycosis and their application for appropriate treatment, J Fungi 2019; 5(1):1-22.

10. Méndez L, Manzano P, Rangel R, Silva I, Hernández F y López R, Frecuencia de onicomicosis por hongos filamentosos no dermatofitos en un hospital de tercer nivel, Dermatol Rev Mex 2013; 57:235-9.

11. Thomas B, Audonneau NC, Machouart M y Debourgogne A, Fusarium infections: epidemiological aspects over 10 years in a university hospital in France, J Infect Public Health 2020; 13(8):1089-93.

12. Rosa PD, Heidrich D, Corrêa C, Scroferneker ML, Vettorato G, Fuentefria A et al., Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis, Mycoses 2017; 60(9):616-22.

13. Ranawaka RR, Nagahawatte A y Gunasekara TA, Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases, Int J Dermatol 2015; 54(11):1275-82.

14. Dutta P, Premkuma A, Chakrabarti A, Shah V, Behera A y Bhansali A, Fusarium falciforme infection of foot in a patient with type 2 diabetes mellitus: a case report and review of the literatura, Mycopathologia 2018; 176(3-4): 225.